2-((4-Oxospiro[chroman-2,1'-cyclohexan]-6-yl)oxy)acetic acid

Catalog No. :
ACYNSC782
CAS No. :
135111-35-2
Molecular Formula :
C16H18O5
Molecular Weight :
290.32

IUPAC Name:2-((4-oxospiro[chromane-2,1'-cyclohexan]-6-yl)oxy)acetic acid

2-((4-Oxospiro[chroman-2,1'-cyclohexan]-6-yl)oxy)acetic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$157.00Login to see priceInquiryInquiry
1g95%$391.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-((4-Oxospiro[chroman-2,1'-cyclohexan]-6-yl)oxy)acetic acid
IUPAC Name2-((4-oxospiro[chromane-2,1'-cyclohexan]-6-yl)oxy)acetic acid
MDL No.MFCD03830327
Molecular FormulaC16H18O5
Molecular Weight290.32
SMILESO=C(O)COC1=CC(C(CC2(CCCCC2)O3)=O)=C3C=C1
InChI KeyDHVARIMZVITILK-UHFFFAOYSA-N
Synonym[(4-oxo-3,4-dihydrospiro[chromene-2,1'-cyclohexan]-6-yl)oxy]acetic acid;2-(4-ketospiro[chroman-2,1'-cyclohexane]-6-yl)oxyacetic acid;2-(4-oxospiro[chroman-2,1'-cyclohexane]-6-yl)oxyacetic acid;2-(4-oxospiro[chroman-2,1'-cyclohexane]-6-yl)oxyethanoic acid;2-[(4-oxo-6-spiro[chroman-2,1'-cyclohexane]yl)oxy]acetic acid;ChemDiv2_003122;EU-0096495;ST075838
CAS No.135111-35-2

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYNSC782 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYNSC782 route product structure diagram
    ACYNSC782135111-35-2
Inquiry

2. ACYNSC782 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACYNSC782 route product structure diagram
    ACYNSC782135111-35-2
Inquiry

Comments (0)